This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Express 4 Image Cytometry Is Compatible With PerkinElmer's Opera, Harmony And Columbus Software

LOS ANGELES, Jan. 7, 2013 /PRNewswire/ -- Express 4 Image Cytometry Software will be able to read data from PerkinElmer's Opera, and Operetta instruments as well as the Columbus database. FCS Express will be able to import images, segmentation and feature data from these platforms.

Leveraging a long history of excellence in Flow Cytometry data analysis, De Novo Software launched FCS Express 4 Image Cytometry in January of 2011. The new software adds the ability to access and interactively perform population-based analysis, while linking back to the individual images that underlie the data. This enables highlighting of individual cells in an image from selected populations or display of single cells of interest in separate cell galleries. These tools significantly improve assay development, workflow, and enable rapid report generation.

David Novo, De Novo Software's president, said: "Partnering with PerkinElmer gives FCS Express 4 Image Cytometry users the ability to access data from the sophisticated instrumentation the PerkinElmer provides. We are particularly excited about compatibility with PerkinElmer's Columbus database, which allows us to analyze image data derived from almost any instrument."

"Now that scientists can transfer data from PerkinElmer's Columbus, Opera and Operetta systems to De Novo's FCS Express 4 Image Cytometry software they are able to get mine these rich data sets more fully than ever before," says Dr. Martin Daffertshofer, Portfolio Director Scientific Imaging Software at PerkinElmer. "This enables scientists to use image cytometry and high content screening as complementary techniques in their workflow to classify cells.  Initial customers who have used the tools together have been extremely enthusiastic about the new capabilities."

In FCS Express 4 analytical tools for flow and image cytometry and High Content Screening are combined into one environment with report generation and on-line collaboration tools.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 0.00%
FB $117.43 0.00%
GOOG $692.36 0.00%
TSLA $232.32 0.00%
YHOO $36.01 0.00%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs